Benjamin Li
Mar 5, 2010

Mindshare, Aegis Media, OMD and ZenithOptimedia vie for Xian-Janssen Pharmaceutical media planning account in China

BEIJING - Johnson & Johnson owned Xian-Janssen Pharmaceutical Company has called a media planning review in China.

Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Mindshare, Aegis Media, OMD and ZenithOptimedia are understood to be involved in the pitch.

According to agency sources, the account is a “good size and meaningful” and is worth an estimated US$15 million.

OMD holds the media buying account for Johnson & Johnson. The agency won the business in 2007, which also includes Shanghai Johnson & Johnson Pharmaceuticals and Johnson & Johnson Vision Care.

Motilium and Daktarin are among Xian-Janssen Pharmaceutical's main products in China.


 
Source:
Campaign China

Related Articles

Just Published

2 hours ago

Creative Minds: Heidi Kasselman on how pretending ...

From winging an internship in Johannesburg to leading creative at Clemenger, Heidi Kasselman's unconventional path proves sometimes chaos is the best career plan.

3 hours ago

Veteran Australian broadcaster Alan Jones arrested ...

One of the country's most influential yet controversial media figures, Jones has been detained following an investigation into alleged offences spanning nearly two decades.

3 hours ago

40 Under 40 2024: Jacob Lin, Leap Strategy

A 29-year-old CEO, Lin is redefining digital marketing in China, blending purpose with profit to transform brand engagement with talent and consumers alike.

3 hours ago

Agency of the Year 2024: Shortlists announced

See the full shortlist for the 2024 Campaign Asia-Pacific Agency of the Year awards here. Tickets are limited, we encourage you to secure your spot fast.